Global Mass Spectrometry Devices Market Segmentation, By Technology (Hybrid Mass Spectrometry, Single Mass Spectrometry, and Others), Application (Biotechnology, Clinical Research, Diagnostics and Environmental Testing, Drug Discovery, Metabolomics, Pharmaceutical, Proteomics, and Others), End-User (Institutes and Research Centers, Medical, Pharmaceutical and Biopharmaceutical Companies, Suppliers and Distributors of Mass Spectrometry System, and Others) – Industry Trends and Forecast to 2031.
Mass Spectrometry Devices Market Analysis
Mass spectrometry devices market continues to evolve with advancements in high-resolution imaging, enhanced sensitivity, and faster analysis times. Applications span pharmaceuticals, environmental monitoring, and clinical diagnostics. Innovations such as MALDI-TOF and triple quadrupole systems drive growth, addressing complex analytical challenges. Market expansion is fueled by increasing demand for precision medicine and quality control across industries.
Mass Spectrometry Devices Market Size
The global mass spectrometry devices market size was valued at USD 6.97 billion in 2023 and is projected to reach USD 11.34 billion by 2031, with a CAGR of 6.27% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Hybrid Mass Spectrometry, Single Mass Spectrometry, and Others), Application (Biotechnology, Clinical Research, Diagnostics and Environmental Testing, Drug Discovery, Metabolomics, Pharmaceutical, Proteomics, and Others), End-User (Institutes and Research Centers, Medical, Pharmaceutical and Biopharmaceutical Companies, Suppliers and Distributors of Mass Spectrometry System, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Bruker (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc. (U.S.), Shimadzu Corporation (Japan), KORE TECHNOLOGY (Japan), LECO Corporation (U.S.), JEOL Ltd. (Japan), Eurofins Scientific (Luxembourg), Ion Science Ltd (U.K.), Teledyne FLIR LLC (U.S.), AMETEK.Inc. (U.S.), and Hiden Analytical (U.K.)
|
|
Market Opportunities
|
|
Mass Spectrometry Devices Market Definition
Mass spectrometry devices analyze chemical substances by measuring their mass-to-charge ratios and producing mass spectra. These instruments are crucial in various fields such as chemistry, biochemistry, and environmental science for identifying compounds, quantifying molecules, and studying molecular structures. They operate by ionizing samples, separating ions based on mass, and detecting ion signals to provide detailed molecular information with high sensitivity and accuracy.
Mass Spectrometry Devices Market Dynamics
Drivers
- Growing Adoption in Proteomics and Metabolomics
The growing adoption of mass spectrometry in proteomics and metabolomics research is driving market demand. These techniques are essential for studying proteins and metabolites, crucial in biomarker discovery for diseases such as cancer. For instance, mass spectrometry enables precise identification and quantification of biomarkers in patient samples, facilitating personalized medicine approaches. This capability supports advancements in metabolic profiling, enhancing understanding and treatment strategies, thereby fueling the expansion of mass spectrometry device usage.
- Increasing Drug Development Activities
The pharmaceutical industry's expanding pipeline of new drug candidates necessitates advanced analytical tools for precise drug characterization and quality assurance. Mass spectrometry devices play a pivotal role in this process by enabling detailed analysis of drug compounds, metabolites, and impurities. For instance, mass spectrometers are crucial in determining the purity and structural integrity of biopharmaceuticals, ensuring regulatory compliance and enhancing drug efficacy and safety profiles, thereby driving significant growth in the market.
Opportunities
- Increasing Research and Development
The increasing investments in research and development by pharmaceutical and biotechnology companies create significant opportunities in the mass spectrometry market. These firms rely on high-performance analytical tools such as mass spectrometers for advancing drug discovery, proteomics, and metabolomics studies. For instance, the development of novel biomarkers and precision medicine approaches requires sophisticated mass spectrometry technologies, driving the demand for innovative solutions and expanding the market's growth potential.
- Increasing Drug Development Activities
Increasing drug development activities in the pharmaceutical industry necessitate advanced analytical tools such as mass spectrometry for drug characterization and quality control. This demand creates opportunities for market growth as companies seek precise and reliable methods to ensure the safety and efficacy of new drug candidates. For instance, mass spectrometry facilitates the accurate determination of drug purity and the detection of impurities, crucial for meeting regulatory standards and advancing drug development processes.
Restraints/Challenges
- High Initial Costs
The high initial costs associated with mass spectrometry devices pose a significant barrier to market entry and adoption, particularly for smaller laboratories and research facilities. These expenses encompass both purchase and maintenance, limiting affordability and accessibility. As a result, many potential users are unable to justify the investment, hindering widespread adoption and market expansion.
- Sample Preparation Challenges
Sample preparation for mass spectrometry poses significant challenges due to its complexity and variability. The intricate procedures required to achieve accurate results lead to inconsistencies in sample quality and preparation techniques. This variability undermines the reliability and consistency of outcomes, hindering the mass spectrometry market's growth and adoption. Such challenges necessitate meticulous attention to detail and rigorous standardization efforts to mitigate potential drawbacks in analytical accuracy and data interpretation.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Mass Spectrometry Devices Market Scope
The market is segmented on the basis technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Hybrid Mass Spectrometry
- Triple Quadrupole (tandem)
- Quadrupole TOF (Q-TOF)
- Fourier Transform Mass Spectrometry (FTMS)
- FT-ICR MS
- Orbit-Rap
- Single Mass Spectrometry
- ION Trap
- Quadrupole and Time-of-Flight (TOF)
- Others
Application
- Biotechnology
- Clinical Research
- Diagnostics and Environmental Testing
- Drug Discovery
- Metabolomics
- Pharmaceutical
- Proteomics
- Others
End-User
- Institutes and Research Centers
- Medical
- Pharmaceutical and Biopharmaceutical Companies
- Suppliers and Distributors of Mass Spectrometry System
- Others
Mass Spectrometry Devices Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, technology, application and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the mass spectrometry devices market, driven by increased research funding. Government initiatives and widespread applications in metabolomics and petroleum sectors will bolster growth in the region during the forecast period.
Asia-Pacific is projected to observe significant growth in the mass spectrometry devices market due to increased demand for advanced MS devices. Rising awareness is expected to further propel market growth in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Mass Spectrometry Devices Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Agilent Technologies, Inc. (U.S.)
- Danaher Corporation (U.S.)
- Waters Corporation (U.S.)
- Bruker (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- PerkinElmer Inc. (U.S.)
- Shimadzu Corporation (Japan)
- KORE TECHNOLOGY (Japan)
- LECO Corporation (U.S.)
- JEOL Ltd. (Japan)
- Eurofins Scientific (Luxembourg)
- Ion Science Ltd (U.K.)
- Teledyne FLIR LLC (U.S.)
- AMETEK.Inc. (U.S.)
- Hiden Analytical (U.K.)
Latest Developments in Mass Spectrometry Devices Market
- In June 2023, Thermo Fisher Scientific, Inc. unveiled the Thermo ScientificTM OrbitrapTM AstralTM mass spectrometer. This advanced analyzer facilitates precise protein identification, crucial for groundbreaking discoveries in clinical biomarkers, diseases, and therapies
- In June 2023, Agilent Technologies, Inc. introduced the Inspirational LC/TQ and LC/Q-TOF Mass Spectrometry Solutions. The Agilent 6495 Triple Quadrupole LC/MS excels in targeted analysis with exceptional sensitivity. The Agilent Revident Quadrupole Time-of-Flight LC/MS (LC/QTOF) System features intelligent architecture for enhanced operational efficiency and productivity
- In June 2022, Shimadzu Scientific Instruments launched the LCMS-2050 liquid chromatography quadrupole mass spectrometer. Notably compact, it offers high-speed and high-sensitivity analysis capabilities
- In March 2022, Waters Corporation released the Xevo TQ Absolute system, a compact benchtop tandem mass spectrometer. Boasting up to 15 times greater sensitivity for quantifying negatively ionizing compounds than its predecessor, it also reduces size by 45% and decreases electricity and gas consumption by up to 50%
SKU-